Dan Hicklin
Managing Director @ MPM Capital
Cambridge, United States
Dan Hicklin is a venture - series unknown investor at MPM Capital in Cambridge focused on Biopharma and Therapeutics. Dan Hicklin, Ph.D., joined MPM in 2014 subsequent to his successful role as President & Chief Scientific Officer and member of the Board of CoStim Pharmaceuticals (acquired by Novartis:NVS). He now serves as President and CEO of Potenza Therapeutics, an immuno-oncology company founded by MPM. Dan is also a board member of Tizona Therapeuticsand Harpoon Therapeutics, two MPM portfolio companies.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Dan Hicklin invests in
Stages Dan Hicklin invests in
Countries Dan Hicklin invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biopharma 1 (100%)
- Therapeutics 1 (100%)
- Biotechnology 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Potenza Therapeutics
|
Potenza Therapeutics, Inc. is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs that utilize the body’s own immune system to seek out, recognize and destroy tumors through a diversity of mechanisms that influence tumor immunity. It was founded in 2014 and headquartered in Cambridge, Massachusetts. | $30M / Venture - Series Unknown / Mar 17, 2016 |
Co-Investors
About MPM Capital
MPM Capital is a healthcare investment firm that invests in companies developing therapeutic technologies in oncology. The company invests in life sciences companies that seek to cure diseases by translating science into clinical outcomes. The company prefers to invest in the biotechnology, healthcare, and life sciences sectors.
MPM Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Dan Hicklin
Managing Director
|
|||
David P. Ryan
Medical and Scientific Advisor
|
|||
Detlev Biniszkiewicz
Executive Partner
|
|||
Patrick Baeuerle
Excutive Partner
|
|||
Uciane Scarlett
Principal
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Dan Hicklin invest in?
Dan Hicklin invests primarily in Biopharma, Therapeutics and Biotechnology startups, most often at Venture - Series Unknown stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Dan Hicklin?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Dan Hicklin last invest?
The most recent investment recorded for Dan Hicklin closed in Mar 2016. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
